Treating muscle-specific kinase myasthenia gravis from the inside out

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 12;7(1):e646. doi: 10.1212/NXI.0000000000000646. Print 2020 Jan.

Authors

Maartje G Huijbers¹, Jan J G M Verschuuren²

Affiliations

¹ From the Department of Neurology (M.G.H., J.J.G.M.V.) and Department of Human Genetics (M.G.H.), Leiden University Medical Center, The Netherlands.
² From the Department of Neurology (M.G.H., J.J.G.M.V.) and Department of Human Genetics (M.G.H.), Leiden University Medical Center, The Netherlands. J.J.G.M.Verschuuren@lumc.nl.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Fatty Acids, Monounsaturated
Humans
Myasthenia Gravis*
Receptor Protein-Tyrosine Kinases
Receptors, Cholinergic

Substances

Fatty Acids, Monounsaturated
Receptors, Cholinergic
musk
MUSK protein, human
Receptor Protein-Tyrosine Kinases